Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?
Hepatobiliary Surg Nutr
.
2023 Aug 1;12(4):631-633.
doi: 10.21037/hbsn-23-255.
Epub 2023 Jul 3.
Authors
Iakovos Amygdalos
1
,
Ulf Peter Neumann
1
,
Sven Arke Lang
1
Affiliation
1
Department of General, Visceral and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, Germany.
PMID:
37600990
PMCID:
PMC10432298
DOI:
10.21037/hbsn-23-255
No abstract available
Keywords:
Cholangiocarcinoma (CCA); biomarkers; targeted therapy.
Publication types
Editorial
Comment